| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |